Determining whether Healius represents an attractive purchase at current valuation levels requires evaluating its operational turnaround progress against lingering sector headwinds and past unprofitability. Value investors drawn to essential healthcare infrastructure and potential recovery plays may find the stock compelling following significant corporate restructuring, but risk-averse participants often prefer waiting for sustained positive net earnings and consistent margin expansion before initiating positions.